Primary Job Title Senior Vice President and Chief Financial Officer Primary Organization 
Wyeth's Global R&D Enterprise
Gender Male
LinkedIn View on LinkedIn
Greg Norden is the Managing Director of G9 Capital Group, LLC, which invests in early stage ventures and provides corporate finance advisory services. From 1989 to 2010, Greg Norden held various senior positions with Wyeth/American Home Products, most recently as Wyeth’s Senior Vice President and Chief Financial Officer. Prior to this role,
Greg Norden was Executive Vice President and Chief Financial Officer of Wyeth Pharmaceuticals. Prior to his affiliation with Wyeth, Greg Norden served as Audit Manager of Arthur Andersen & Co. Greg Norden serves on the Board of Directors of NanoString, a provider of life science tools for translational research and molecular diagnostic products, Royalty Pharma, a leader in the acquisition of revenue-producing intellectual property, Univision, the leading media company serving Hispanic America, and Zoetis, the leading animal health company. Greg Norden is a former director of Welch Allyn, where he served until 2015, Lumara Health, where he served until 2014, and Human Genome Sciences, where he served until 2012.
